T.B.Fruit, one of the largest processors of fruits and berries in Ukraine, has begun the construction of the eighth plant of the group for processing fruits and berries in Brzostowiec (Poland), investment in which will amount to EUR45 million, founder of T.B.Fruit Taras Barschovsky has said. “The capacity for apple processing will be 300,000 tonnes, strawberries 10,000 tonnes, cherries 6,000 tonnes, raspberries 12,000 tonnes, currants some 7,000 tonnes per year. Production start is scheduled for July 2020,” he told the Interfax-Ukraine agency.
According to Barschovsky, investments in the plant are estimated at EUR45 million.
T.B.Fruit is a vertically integrated international group of companies with a closed production cycle (growing raw materials, processing, transportation).
The group of companies was established in July 2011 after the consolidation of all the assets of businessman Taras Barschovsky.
Energoatom has announced a tender for the supply of equipment and materials for the solar power plant Sonechko-1, which is to be built in the territory of Zaporizhia nuclear power plant (NPP).
According to the ProZorro system, the corresponding auction is scheduled for June 24. The expected cost of work is UAH 270.52 million.
Energoatom proposes to supply 48,900 single-crystal or polycrystalline Risen photovoltaic modules with a capacity of 310–320 W, some 360 network inverters, 13 complete substations of 0.4/6 kV and one substation of 35/6kV, as well as 119,300 meters of copper cable.
Energoatom announced the intention to build a solar plant with a capacity of about 15 MW at Zaporizhia NPP in 2017. Since then, there have been preparatory work: design, geodetic studies. It was assumed that the solar station will be located on 37 hectares, in the territory of hydraulic structures between the cooling pond and the Kaniv water reservoir.
BUILD, ENERGOATOM, NUCLEAR POWER, PLANT, SOLAR PLANT, TENDER
UFuture Investment Group has opened Plank Electrotechnic, Ukraine’s first plant to produce modern electrotechnical systems. The building of the enterprise meets international BREEAM sustainability standards (compliance with about 50 criteria for environmental construction). Plank Electrotechnic products are now undergoing EU certification procedures.
“We have invested $2.8 million in the enterprise and expect to return the investment within five years. The Ukrainian market is a priority, but the company plans to expand the outreach to Eastern European consumers. I believe that the development of modern technological industries is a very promising area, both from business and social points of view – it is not only profit, but also taxes and jobs,” Vasyl Khmelnytsky, the founder of UFuture, has said.
Plank Electrotechnic will produce about 4.6 million units annually and will compete mainly with Chinese and Turkish manufacturers on the Ukrainian market. This high-tech enterprise will produce electrical fittings, accessories and components: sockets, switches, mounting boxes, cable ties, buttons, etc.
“Opening a new plant marks the beginning of the development of Plank innovative production cluster at Bila Tserkva Industrial Park which will make goods from high-tech materials in the field of electrical engineering, construction and mechanical engineering. We offer entrepreneurs who plan to work in these areas to quickly scale their businesses without unnecessary administrative and bureaucratic obstacles,” Chief Executive Officer of Bila Tserkva Industrial Park Volodymyr Khmurych has said.
The construction of three new plants at Bila Tserkva Industrial Park will start within the year, and 20 modern enterprises will be created in the next four years.
ADDITIONAL INFORMATION
UFuture is a Ukrainian private equity firm and group of companies, based in Kyiv. UFuture consolidates UDP, which is a real estate development company specialized in large infrastructure projects, the country’s second biggest Kyiv Sikorsky international airport, national Ukrainian outdoor advertising operator RTM, and Bila Tserkva industrial park. The group develops new and innovative businesses such as renewable energy generator UDP Renewables, pharmaceutical producer Biopharma, and innovation parks UNIT.City and LvivTech.City. UFuture supports and coordinates numerous impact and sustainability projects related to education and economics, some of which are annual Kyiv International Economic Forum, Small and Medium Entrepreneurship School, cutting-edge IT coding school UNIT Factory and Lean Institute Ukraine.
Bila Tserkva Industrial Park is a large-scale investment project aimed at facilitating establishment of modern manufacturing in Ukraine. It is a one-window platform that allows producers to access all necessary assets, utilities and services and focus on the development of their businesses. The park offers industrial land and property with all engineering infrastructure for rent or purchase, turn-key solutions and a possibility of co-investment in manufacturing. Local market insight and substantial experience in real estate development allows the park’s team to provide clients with additional consulting services on setting up an efficient production.
Persey Energo LLC intends to build a biogas plant with an electrical capacity of 12 MW at Persey Agro farm (Ivano-Frankivsk region).
This is evidenced by the report about the planned activities in the unified register of environmental impact assessment, posted on the website of the Ministry of Ecology and Natural Resources.
It is planned that the plant will recycle organic waste from agriculture and animal breeding. It is assumed that the plant will generate 12 million kWh of electricity and 7.288 million kWh of heat per year.
According to the state register of legal entities, at the end of March the founders of Persey Energo LLC, registered in 2018, were five individuals and Alliance-Invest IF LLC. Persey Agro belongs to Volodymyr Slobodian.
Eurocar (Solomonove, Zakarpattia region), manufacturing Skoda passenger cars, part of Atoll Holding Group, tentatively saw UAH 182 million in net profit in 2018, which is 2.6 times more than in 2017.
According to the information attached to the agenda of the general meeting of shareholders scheduled for April 25, its uncovered loss as of early 2019 totaled UAH 1.11 billion (UAH 734.24 million in 2017).
According to the draft decision of the shareholders, it is planned to send net profit for 2018 to cover losses of the previous years.
In 2018, Eurocar saw a 7.3% rise in current liabilities, to UAH 372.93 million, while noncurrent liabilities slightly grew to UAH 1.625 billion.
Total receivables as of January 1, 2019 accounted for UAH 426.61 million, falling by 22.4%, and its assets grew by 50.2%, to UAH 2.303 billion.
Net worth as of early 2019 was UAH 304.42 million, while a year ago it was negative – UAH 429.438 million. The charter capital did not change, being UAH 234.48 million.
Eurocar has been manufacturing passenger cars since December 2001.
Biopharma, a manufacturer of products from human donor plasma, has begun commissioning work at a new fractionator plant, which is being built in Bila Tserkva (Kyiv region).
“Biopharma has started commissioning work at the new plant,” Kostiantyn Yefymenko, the head of the board of directors of the Biopharma group of companies, said on his Facebook page.
According to him, at present, the plant has already launched warehouses for raw materials and finished products, while systems for water supply, chilled water, water for injection, steam, diethylene glycol, compressed air, purified air, neutralization of waste water are being tested.
As reported, investment in the construction of a new plant fractionator of blood plasma amounted to about $50 million. The plant will have three lines for the production of albumin, immunoglobulin, and factor VIII. The processing capacity ranges from 250,000 to one million liters of plasma per year. Biopharma planned to put it into operation at the end of 2018.
Biopharma immunobiological pharmaceutical company is among the ten largest Ukrainian manufacturers of drugs. It produces more than 20 immunobiological preparations from donated blood plasma, preparations obtained by recombinant DNA technology and probiotics.
